TP53 and colorectal neoplasm: Loss of PHD1 gene function attenuates p53 activation and reduces p53 phosphorylation at Ser15 which leads to an increased sensitivity of colorectal tumor cells to chemotherapy treatment in vivo and in vitro [50].